arrow
返回
C

Christopher L. Gilbert

University of Trento

38H指数
242论文数
7.1K被引数
收录论文 39
发表时间
A Phase III, multicenter, randomized, double-blind, active comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of V114 compared with PCV13 in healthy infants (PNEU-PED-EU-1) (vol 41, pg 3387, 2023)一项III期、多中心、随机、双盲、活性对照比较研究,旨在评估V114相较于PCV13在健康婴儿中的安全性、耐受性和免疫原性(PNEU-PED-EU-1)(卷41,页3387,2023)。
errVACCINE
IF3.5
err2025-02-01
err0
PREAI
errMartinon-Torres, Federico; Wysocki, Jacek; Szenborn, Leszek; Carmona-Martinez, Alfonso; Poder, Airi; Dagan, Ron; Richmond, Peter; Gilbert, Christopher; Trudel, Marie-Chantale; Flores, Sheryl; Lupinacci, Robert; Mcfetridge, Richard; Wiedmann, Richard T.; Chen, Qiuxu; Gerrits, Han; Banniettis, Natalie; Musey, Luwy; Bickham, Kara; Kaminski, Janusz
err分享
err收藏
Cytomegalovirus Antiviral Resistance Among Kidney Transplant Recipients in a Phase 3 Trial of Letermovir vs Valganciclovir Prophylaxis
err2024-06-10
err0
errOAAI
errStrizki, Julie M.; Diamond, Tracy L.; Teal, Valerie L.; Gilbert, Christopher L.; Wang, Weiwen; Stauffer, Nicole; Haber, Barbara A.
err分享
err收藏
Letermovir vs Valganciclovir for Prophylaxis of Cytomegalovirus in High-Risk Kidney Transplant Recipients A Randomized Clinical Trial
err2023-07-03
err85
errOAAI
errLimaye, Ajit P.; Budde, Klemens; Humar, Atul; Vincenti, Flavio; Kuypers, Dirk R. J.; Carroll, Robert P.; Stauffer, Nicole; Murata, Yoshihiko; Strizki, Julie M.; Teal, Valerie L.; Gilbert, Christopher L.; Haber, Barbara A.
err分享
err收藏
err分享
err收藏
err分享
err收藏
Competitive Storage, Biofuels and the Corn Price
err2019-10-28
err11
PREAI
errGilbert, Christopher L.; Mugera, Harriet Kasidi
err分享
err收藏
Elbasvir/grazoprevir and sofosbuvir for hepatitis C virus genotype 3 infection with compensated cirrhosis: A randomized trialElbasvir/grazoprevir和sofosbuvir治疗丙型肝炎病毒基因型3感染并代偿期肝硬化: 一项随机试验
err2018-04-19
err18
errOAAI
errFoster, Graham R.; Agarwal, Kosh; Cramp, Matthew E.; Moreea, Sulleman; Barclay, Stephen; Collier, Jane; Brown, Ashley S.; Ryder, Stephen D.; Ustianowski, Andrew; Forton, Daniel M.; Fox, Ray; Gordon, Fiona; Rosenberg, William M.; Mutimer, David J.; Du, Jiejun; Gilbert, Christopher L.; Asante-Appiah, Ernest; Wahl, Janice; Robertson, Michael N.; Barr, Eliav; Haber, Barbara
err分享
err收藏
ELBASVIR/GRAZOPREVIR PLUS SOFOSBUVIR IN TREATMENT-NAIVE AND TREATMENT-EXPERIENCED CIRRHOTIC PATIENTS WITH HEPATITIS C VIRUS GENOTYPE 3 INFECTION TREATED FOR 8, 12 OR 16 WEEKS: FINAL RESULTS OF THE C-ISLE STUDY
err2017-04-01
err1
PREAI
errHaber, Barbara; Foster, Graham R.; Agarwal, Kosh; Cramp, Matthew E.; Moreea, Sulleman; Barclay, Stephen; Collier, Jane; Brown, Ashley S.; Ryder, Stephen D.; Ustianowski, Andrew; Forton, Daniel; Fox, Raymond; Gordon, Fiona; Rosenberg, William; Mutimer, David J.; Du, Jiejun; Gilbert, Christopher L.; Robertson, Michael; Barr, Eliav
err分享
err收藏
Food price seasonality in Africa: Measurement and extent
err2017-02-01
err86
errOAAI
errGilbert, Christopher L.; Christiaensen, Luc; Kaminski, Jonathan
err分享
err收藏
Grazoprevir, Elbasvir, and Ribavirin for Chronic Hepatitis C Virus Genotype 1 Infection After Failure of Pegylated Interferon and Ribavirin With an Earlier-Generation Protease Inhibitor: Final 24-Week Results From C-SALVAGE
err2015-09-14
err82
errOAAI
errButi, Maria; Gordon, Stuart C.; Zuckerman, Eli; Lawitz, Eric; Calleja, Jose L.; Hofer, Harald; Gilbert, Christopher; Palcza, John; Howe, Anita Y. M.; DiNubile, Mark J.; Robertson, Michael N.; Wahl, Janice; Barr, Eliav; Forns, Xavier
err分享
err收藏
Grazoprevir and elbasvir plus ribavirin for chronic HCV genotype-1 infection after failure of combination therapy containing a direct-acting antiviral agent
err2015-09-01
err122
PREAI
errForns, Xavier; Gordon, Stuart C.; Zuckerman, Eli; Lawitz, Eric; Calleja, Jose L.; Hofer, Harald; Gilbert, Christopher; Palcza, John; Howe, Anita Y. M.; DiNubile, Mark J.; Robertson, Michael N.; Wahl, Janice; Barr, Eliav; Buti, Maria
err分享
err收藏
C-SALVAGE: GRAZOPREVIR (GZR; MK-5172), ELBASVIR (EBR; MK-8742) AND RIBAVIRIN (RBV) FOR CHRONIC HCV-GENOTYPE 1 (GT1) INFECTION AFTER FAILURE OF DIRECT-ACTING ANTIVIRAL (DAA) THERAPY
err2015-04-01
err6
PREAI
errForns, X.; Gordon, S.; Zuckerman, E.; Lawitz, E.; Buti, M.; Calleja Panero, J.; Hofer, H.; Gilbert, C.; Palcza, J.; Howe, A.; DiNubile, M.; Robertson, M.; Wahl, J.; Barr, E.; Sullivan-Bolyai, J.
err分享
err收藏
Virologic Resistance Analysis From a Phase 2 Study of MK-5172 Combined With Pegylated Interferon/Ribavirin in Treatment-Naive Patients With Hepatitis C Virus Genotype 1 Infection
err2014-09-28
err39
errOAAI
errHowe, Anita Y. M.; Black, Stuart; Curry, Stephanie; Ludmerer, Steven W.; Liu, Rong; Barnard, Richard J. O.; Newhard, William; Hwang, Peggy M. T.; Nickle, David; Gilbert, Christopher; Caro, Luzelena; DiNubile, Mark J.; Mobashery, Niloufar
err分享
err收藏
The Combination of MK-5172, Peginterferon, and Ribavirin Is Effective in Treatment-Naive Patients With Hepatitis C Virus Genotype 1 Infection Without Cirrhosis
err2014-08-01
err33
errOAAI
errManns, Michael P.; Vierling, John M.; Bacon, Bruce R.; Bruno, Savino; Shibolet, Oren; Baruch, Yaacov; Marcellin, Patrick; Caro, Luzelena; Howe, Anita Y. M.; Fandozzi, Christine; Gress, Jacqueline; Gilbert, Christopher L.; Shaw, Peter M.; Cooreman, Michael P.; Robertson, Michael N.; Hwang, Peggy; Dutko, Frank J.; Wahl, Janice; Mobashery, Niloufar
err分享
err收藏
err分享
err收藏
SAFETY AND EFFICACY OF MK-5172 PLUS PEGINTERFERON ALFA-2b AND RIBAVIRIN (PR) IN CIRRHOTIC AND NON-CIRRHOTIC TREATMENT-NAIVE PATIENTS WITH HEPATITIS C VIRUS (HCV) GENOTYPE (G)1 INFECTION
err2014-04-01
err0
PREAI
errHezode, C.; Bruno, S.; Jacobson, I.; Serfaty, L.; Kwo, P.; Zhou, A.; Gilbert, C.; Hwang, P.; Wahl, J.; Robertson, M. N.; Mobashery, N.
err分享
err收藏
RELATIONSHIP BETWEEN TRANSAMINASE LEVELS AND PLASMA PHARMACOKINETICS FOLLOWING ADMINISTRATION OF MK-5172 WITH PEGYLATED INTERFERON alfa-2b AND RIBAVIRIN (PR) TO HCV GENOTYPE (G) 1 TREATMENT-NAIVE PATIENTS
err2013-04-01
err7
errOAAI
errCaro, L.; Du, L.; Huang, S.; Wenning, L.; Su, J.; Hwang, P. M. T.; Valesky, R.; Gilbert, C.; Gress, J.; Klaassen, F.; Gendrano, I. N.; Brunhofer, J.; Cooreman, M.; Huisman, J.; Mobashery, N.
err分享
err收藏
HIGH SUSTAINED VIRAL RESPONSE AT 12-AND 24-WEEK FOLLOW-UP OF MK-5172 WITH PEGYLATED INTERFERON alfa-2b AND RIBAVIRIN (PR) IN HCV GENOTYPE 1 TREATMENT-NAIVE NON-CIRRHOTIC PATIENTS
err2013-04-01
err10
PREAI
errManns, M.; Vierling, J. M.; Bacon, B. R.; Marcellin, P.; Caro, L.; Gress, J.; Gilbert, C.; Cooreman, M. P.; Robertson, M.; Hwang, P.; Wahl, J.; Mobashery, N.
err分享
err收藏
MK-5172 IN COMBINATION WITH PEG-INTERFERON/RIBAVIRIN DEMONSTRATES ROBUST EFFICACY AND A LOW RATE OF RESISTANCE-ASSOCIATED VIROLOGIC FAILURE IN TREATMENT NAIVE GENOTYPE 1 CHRONIC HCV-INFECTED PATIENTS
err2013-04-01
err1
PREAI
errHowe, A.; Ludmerer, S.; Liu, R.; Black, S.; Barnard, R.; Newhard, W.; Graham, D.; Nickle, D.; Hwang, P.; Gilbert, C.; Mobashery, N.
err分享
err收藏